Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1648 SEK | +1.10% | +3.26% | -32.87% |
23/02 | Abliva AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
2023 | Abliva AB Reaches Patient Enrollment Goal for Wave 1 of the FALCON Study | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 222M 20.33M 1.69B |
---|---|---|---|---|---|
Net income 2024 * | -142M -12.98M -1.08B | Net income 2025 * | -157M -14.35M -1.2B | EV / Sales 2024 * | - |
Net cash position 2024 * | 124M 11.33M 945M | Net cash position 2025 * | 173M 15.81M 1.32B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.27
x | P/E ratio 2025 * |
-1.1
x | Employees | 8 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.06% |
1 day | +1.10% | ||
1 week | +3.26% | ||
Current month | +1.60% | ||
1 month | +6.60% | ||
3 months | -31.19% | ||
6 months | -28.50% | ||
Current year | -32.87% |
Managers | Title | Age | Since |
---|---|---|---|
Ellen Donnelly
CEO | Chief Executive Officer | 50 | 03/21/03 |
Eskil Elmér
FOU | Founder | 54 | 01/00/01 |
Director of Finance/CFO | 57 | 01/13/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 69 | 28/16/28 | |
David Bejker
BRD | Director/Board Member | 49 | 27/17/27 |
Eskil Elmér
FOU | Founder | 54 | 01/00/01 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.1648 | +1.10% | 662,886 |
25/24/25 | 0.163 | +1.88% | 932,598 |
24/24/24 | 0.16 | -5.33% | 1,582,808 |
23/24/23 | 0.169 | +1.93% | 1,307,990 |
22/24/22 | 0.1658 | +3.88% | 2,787,638 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 08:59 pm IST
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.87% | 20.21M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ABLI Stock